Baiyang Pharmaceutical (301015.SZ) plans to invest 156 million yuan in Mentougou Baiyang Fund

Zhitongcaijing · 1d ago

Zhitong Finance App News, Baiyang Pharmaceutical (301015.SZ) announced that the company plans to jointly fund the establishment of Baiyang Phase III Pharmaceutical Industry Investment Fund Partnership (limited partnership) with Beijing Baiyang Zhongxin Health Investment Management Co., Ltd., Beijing Mentougou District Jingxi Industry Guidance Fund (limited partnership), and Gongqingcheng Wanheng Venture Capital Partnership (limited partnership) (tentative name, “Mentougou Baiyang Fund”). The pledged capital of Mentougou Baiyang Fund is 400 million yuan. As a limited partner, the company plans to pledge 156 million yuan of capital with its own funds, accounting for 39% of the total investment.

The fund focuses on investing in scientific and technological innovation projects with breakthrough technical drugs, disruptive medical devices, independent intellectual property rights, and filling gaps in the country. The cooperative fund establishment is in line with the company's development strategy and investment direction. The company can forwardly lay out high-quality projects in the pharmaceutical industry through the Mentougou Baiyang Fund layout in fields relevant and collaborative with the company's main business, accurately capture cutting-edge technological trends, continue to broaden the dimensions of the industrial ecological layout, and inject new momentum into long-term innovation and development.